| scholarly article | Q13442814 |
| P2093 | author name string | J. Bockaert | |
| J. Glowinski | |||
| G. Blanc | |||
| J. P. Tassin | |||
| J. Premont | |||
| A. M. Thierry | |||
| P2860 | cites work | Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". | Q34721196 |
| Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs | Q37437347 | ||
| Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain | Q37453753 | ||
| Self-inhibition by Dopaminergic Neurons | Q38160998 | ||
| Dopamine Receptors in the Brain | Q39078920 | ||
| Demonstration of a pallido-nigral projection innervating dopaminergic neurons | Q39337588 | ||
| LSD and dopamine-sensitive adenylate-cyclase in various rat brain areas | Q39936303 | ||
| The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum | Q40003481 | ||
| Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain | Q40331479 | ||
| Dopamine release in substantia nigra? | Q44413004 | ||
| Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase — Interaction of d-LSD with dopaminergic receptors | Q48387933 | ||
| Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. I. Microestimation of [3H]dopamine uptake and dopamine content in microdiscs | Q48387940 | ||
| Release of dopamine from dendrites in rat substantia nigra | Q48397030 | ||
| Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals | Q48479954 | ||
| The origin of the dopamine nerve terminals in limbic and frontal cortex. Evidence for meso-cortico dopamine neurons | Q48497605 | ||
| LSD as an agonist and antagonist at central dopamine receptors | Q48498557 | ||
| Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography | Q48538541 | ||
| Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity | Q48732966 | ||
| Isolation and radioenzymic estimation of picogram quantities of dopamine and norepinephrine in biological samples | Q67444962 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | substantia nigra | Q753278 |
| P304 | page(s) | 99-104 | |
| P577 | publication date | 1976-09-01 | |
| 1976-09-15 | |||
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with 'autoreceptors'? | |
| P478 | volume | 68 |
| Q28643908 | A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions |
| Q72607557 | A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone |
| Q48657904 | Biogenic amine-sensitive adenylate cyclases in primary culture of neuronal or glial cells from mesencephalon |
| Q39644746 | Catecholamine-sensitive adenylate cyclases in nervous tissues |
| Q66939899 | Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area |
| Q40246300 | Cyclic nucleotide phosphodiesterase localization in nerve terminals of the rat substantia nigra |
| Q40123417 | Dendritic release of dopamine in the substantia nigra |
| Q71278026 | Differential effect of haloperidol on DOPAC levels in the substantia nigra and ventral tegmental area |
| Q40208969 | Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus |
| Q39251718 | Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra |
| Q48203128 | Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease |
| Q40243147 | Dopamine receptors in the central nervous system. |
| Q41548498 | Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin |
| Q40093767 | Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro |
| Q69191644 | Dopamine-regulated phosphorylation of synaptic vesicle-associated proteins in rat neostriatum and substantia nigra |
| Q40085825 | Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications |
| Q48641478 | Effects of intranigral injections of dopamine agonists and antagonists, glycine, muscimol and N- methyl-D,L-aspartate on locomotor activity |
| Q39226630 | Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat |
| Q48253796 | Evidence for selective and long-lasting stimulation of “regulatory” dopamine-receptors by bromocriptine (CB 154) |
| Q48475066 | Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro |
| Q71330170 | In vivo 3H-d-LSD binding in small punched out rat brain regions |
| Q39753840 | In vivo measurement of [3H]GABA release: an approach to the study of the regulation of GABA-containing neurons in the basal ganglia and associated structures in the cat and the rat. |
| Q39298281 | Mesolimbic dopaminergic neurones and somatodendritic mechanisms |
| Q37818979 | Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholamines |
| Q48250556 | Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra |
| Q39137711 | Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat |
| Q72474606 | Neuronal, glial and meningeal localizations of neurotransmitter-sensitive adenylate cyclases in cerebral cortex of mice |
| Q48264440 | Nigral and striatal dopamine release under sensory stimuli |
| Q39773343 | Pharmacology and Neurochemistry of Apomorphine |
| Q40094853 | Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis |
| Q43479489 | Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat |
| Q48306174 | Release of dopamine in vivo from cat substantia nigra |
| Q40252604 | Storage and release of amines, amino acids and peptides from dendrites |
| Q40160365 | Subcellular distribution of dopamine in substantia nigra of the rat brain: effects of gamma-butyrolactone and destruction of noradrenergic afferents suggest formation of particles from dendrites |
| Q48722715 | The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigra |
| Q40082826 | The physiology and pharmacology of mammalian basal ganglia |
| Q31804333 | The reverse transport of DA, what physiological significance? |
| Q39199744 | The use of kainic acid in the localization of enzymes in the substantia nigra |
| Q48591326 | Topographical distributions of 32K and 48K cAMP-regulated phosphoproteins: Relationships to dopamine and serotonin innervations in striatum, substantia nigra and cerebral cortex |
| Q40287043 | Ultrastructural observations on intercellular contacts of nigral dendrites |
Search more.